This type of cancer begins in the body’s white blood cells, called lymphocytes, which are part of the immune system. 3 NHL develops when a lymphocyte undergoes a malignant (cancerous) change and then ...

Researchers sought to determine whether the combination therapy DA-EPOCH-R would lead to responses in patients with dual MYC and BCL2-altered DLBCL.

New methods of classifying patients could pave the way for more personalized treatment approaches, a new report states. The methods of subtyping diffuse large B-cell lymphoma (DLBCL) have changed over ...

The authors say their 3D model improves on results using traditional 2-dimensional approaches. A new report suggests a microfluid platform could be a meaningful tool to screen potential new therapies ...

Researchers sought to determine whether adding nivolumab to R-CHOP would be safe and effective in the previously untreated DLBCL setting.

For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. We are so lucky in DLBCL to make more rapid ...

The R-CHOP chemotherapy regimen -- rituximab (Rituxan), cyclophosphamide, doxorubicin, vincristine (Oncovin), and prednisone -- has been the standard first-line therapy in diffuse large B-cell ...

Less than a month after AbbVie and Genmab won FDA approval for Epkinly, Roche has crossed the finish line with its bispecific answer to large B-cell lymphoma. The FDA has granted accelerated approval ...

Please provide your email address to receive an email when new articles are posted on . The addition of brentuximab vedotin to lenalidomide and rituximab improved survival for certain patients with ...

At the recent American Society of Hematology (ASH) meeting, researchers presented early data from a phase II study evaluating mosunetuzumab (Lunsumio) as frontline monotherapy for elderly patients ...

Add Yahoo as a preferred source to see more of our stories on Google. The trial evaluated epcoritamab as a monotherapy against R-GemOx Danish biotechnology company Genmab has announced top line ...